Dendritic-Cell PD-L1 Mediates CD8+ T Cell–Dependent Antitumor Immunity

Article navigation

Research Watch| August 03 2020

Dendritic-Cell PD-L1 Mediates CD8⁺ T Cell–Dependent Antitumor Immunity

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2020

American Association for Cancer Research.

Cancer Discov (2020) 10 (8): OF9.

Deficiency of dendritic cell–expressed PD-L1 reduced tumor growth and increased T-cell infiltration.

2020

American Association for Cancer Research.

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.